A Double-blind, Placebo-controlled, Randomized Dose Ranging Trial to Determine the Safety and Efficacy of Three Dose Levels of EMA401 in Reducing 24-hour Average Pain Intensity Score in Patients With Post-herpetic Neuralgia

Name: A Double-blind, Placebo-controlled, Randomized Dose Ranging Trial to Determine the Safety and Efficacy of Three Dose Levels of EMA401 in Reducing 24-hour Average Pain Intensity Score in Patients With Post-herpetic Neuralgia
Creator: Vivli
Published: 2025-12-16 15:14:03
License: 暂无描述

DataCite Commons2025-12-16 更新2026-05-07 收录

下载链接：

https://search.vivli.org/doiLanding/studies/PR00012267/isLanding

下载链接

链接失效反馈

官方服务：

资源简介：

This study was designed to characterize dose response, and evaluate safety and efficacy of three different doses of EMA401 compared to placebo in patients with post-herpetic neuralgia (PHN).

提供机构：

Vivli

创建时间：

2025-12-16